HEIDELBERG, Germany, December 23, 2008 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509) today received the offer document relating to the mandatory offer by dievini Hopp BioTech holding GmbH & Co. KG. The document has been reviewed and approved by the German Federal Financial Supervisory Authority (BaFin). The SYGNIS management and supervisory board will publish a detailed response statement within the next few days.
